This special podcast discusses the game-changing work going on in Singapore’s N.1 Institute for Health as well as the Institute for Digital Medicine (WisDM) at National. Dean Ho, who runs both institutes, walks us through the use of Artificial Intelligence in transforming the landscape of drug discovery and repurposing, matching patients to clinical trials, and personalised cancer therapy. Dean also highlights Singapore’s powerful ecosystem involving biomedical engineers, clinicians, regulators, and policy makers, with fully aligned incentives that is accelerating progress in these areas. This integrated approach will not only improve care and support innovation, but also keep healthcare costs under control. On COVID-19, Dean points out that his AI system took three days to come up with an optimal drug dose combination to fight the virus, which could be in clinical trial by end of this month. This podcast offers hope and excitement, much needed in these bleak times.

Watch here: https://www.youtube.com/watch?v=CpKcw7dOq-A